NOVO-NORDISK A/S-SPONS ADR (NVO)

See Which Of The Latest 13F Filers Holds Novo-Nordisk

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.

Investors should take note of NYSE:NVO, a growth stock that remains attractively priced.

NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) is showing decent growth, but is still valued reasonably.

March 2025 Options Now Available For Novo-Nordisk (NVO)

Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?

The anti-obesity medication stock is way up, and there could be more fuel in the tank.

Why Amgen Stock Zoomed Nearly 12% Higher Today

The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.

3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030

These under-the-radar stocks have the potential to reach a $1 trillion valuation by 2030 as they gain momentum in their respective industries.

Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review

The Nasdaq regained its 50-day line Friday. The other indexes hit resistance.

AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company?

Amgen (AMGN) stock is soaring after the company's CEO said he was "very encouraged" by interim data for Amgen's new weight-loss drug.

The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?

Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.

This Is a Huge Sigh of Relief for Novo Nordisk Investors

The path is clear for even more growth from Novo Nordisk's top two drugs, Ozempic and Wegovy.

Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript

NVO earnings call for the period ending March 31, 2024.

NVO Stock Earnings: Novo Nordisk Beats EPS, Beats Revenue for Q1 2024

NVO stock results show that Novo Nordisk beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Novo Nordisk Dips As Q1 Wegovy Sales Double, But Miss Target

Novo Nordisk stock came under mild selling pressure early Thursday, after the company reported Q1 results and lifted guidance.

Profit from the Panic: 3 Stocks to Pounce on When They Become Steals

We love it when our favorite clothes go on sale, so when the market offers us a deal, these are the stocks to buy on dips.

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.

While some retail companies are still thriving, investors would be smart to steer clear of these consumer stocks to avoid.

How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.

We also look at the "treasure hunt" economy.

3 of Europe’s ‘Magnificent 18’ Stocks That You Can Buy in the U.S.

The Magnificent Seven is so yesterday. The new trend is to invest in some of the top European stocks, dubbed the Magnificent 18.

Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat

Overall revenue fell short in Q1. Lilly stock is set to cross a key level.

Analyzing NYSE:NVO's Dividend Potential.

Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) provides a good dividend, while having solid fundamentals.

Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks

The "Magnificent Seven" stocks dominate the artificial intelligence (AI) arena. One notable hedge fund manager has three in his top 10 holdings.

A Fed meeting, jobs report, and more Big Tech earnings: What to know this week

After a bounceback week for stocks, a Fed meeting, jobs report, and a busy week of corporate earnings are set to greet investors.

Is Viking Therapeutics Incredibly Undervalued?

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

Forget Nvidia, These Unstoppable Stocks Are Better Buys

These stocks have tremendous potential, and it doesn't depend on the growth prospects for artificial intelligence.

1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On

Eli Lilly may be on the verge of another breakthrough, thanks to its hit GLP-1 medications.

Interesting NVO Put And Call Options For June 7th

Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing?

Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) qualifies as a quality stock.

3 Biotech Stocks With Skyrocketing Potential: April 2024

These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.